SYRASyra Health Corp

Nasdaq www.syrahealth.com


$ 1.52 $ -0.63 (-29.44 %)    

Thursday, 09-May-2024 13:43:31 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 1.51
$ 1.77
$ 0.00 x 0
$ 0.00 x 0
$ 1.36 - $ 1.77
$ 0.81 - $ 8.37
1,050,101
na
9.81M
$ 4.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 syra-health-q1-eps-022-misses-019-estimate-sales-175m-beat-140m-estimate

Syra Health (NASDAQ:SYRA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.19)...

 syra-health-bags-5-year-training-contract-from-sedgwick-county-health-department-in-kansas-to-combat-substance-use-disorder-financial-terms-undisclosed

Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a missio...

 syra-health-secures-statewide-healthcare-contract-in-missouri

Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative s...

 syra-health-q4-eps-016-misses-009-estimate-sales-177m-miss-223m-estimate

Syra Health (NASDAQ:SYRA) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.09)...

 syra-health-expects-fy24-revenue-of-9m-11m-vs-1064m-est

2024 Financial Outlook The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% ve...

 syra-health-fy23-eps-060-vs-070-yoy-revenue-55m-vs-56m-yoy

2023 Financial Highlights2023 revenue of $5.5 million compared to $5.6 million in 2022.Business units excluding Healthcare Work...

 earnings-scheduled-for-march-25-2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

 us-health-agency-reviews-novo-nordisks-wegovy-for-potential-use-in-treating-heart-disease-patients-with-obesity

The CMS is reviewing the FDA's action to expand use of Wegovy to reduce the risk of cardiovascular death, heart attack and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION